Description: Boston Lighthouse Innovation (BLI) was founded to commercialize the Clinical Genomics Suite bioinformatics tools developed at The Massachusetts General Hospital Center for Integrated Diagnostics (MGH-CID). These tools are currently in clinical use at MGH-CID.
OUR MISSION Enable laboratories to launch clinical next generation genomics programs and promote collaboration for the advancement of medical science.
Boston Lighthouse Innovations (BLI) was founded to commercialize the BioBeam Platform, leveraging advanced bioinformatics workflow expertise developed at The Massachusetts General Hospital Center for Integrated Diagnostics (MGH CID). The BioBeam Platform embodies commercial-grade solutions that optimize precision medicine programs and are built on a foundation of proven clinical applications.
More About →